Form D · Other Technology
Stems Labs, Inc.
San Francisco, CA · CIK 0001924506
Offering snapshot reported Apr 25, 2022 · SEC filing
- Reported sold
- $2.41M Offering amount: $4.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 12, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2022 | Initial | $2,405,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-443256
Source: Form D, filed Apr 25, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nikita Bondarenko | Director, Executive, Promoter |
| Haitham El Mengad | Director, Executive, Promoter |
| Christian Vivadelli | Director, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1510 Eddy Street
San Francisco, CA, 94115
San Francisco, CA, 94115